Immunoblot analysis of CD34 expression in histologically diverse neoplasms

American Journal of Pathology

Volumn 156, Issue 1, 2000, Pages 21-27

  Natkunam, Yasodha ^a   Rouse, Robert V ^a   Zhu, Shirley ^a   Fisher, Cyril ^b   Van de Rijn, Matthijs ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CLINICAL ARTICLE; DERMATOFIBROSARCOMA PROTUBERANS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL;

EID: 0033876195     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64701-3     Document Type: Article

References (56)

1. Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors
2. Isolation of a candidate human hematopoietic stem-cell population
3. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells
4. Antigenic analysis of hematopoiesis. V. Characterization of My-10 antigen expression by normal lymphohematopoietic progenitor cells
5. Molecular features of CD34: A hemopoietic progenitor cell-associated molecule
6. Expression of the CD34 gene in vascular endothelial cells
7. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9
8. Prognostic significance of CD34 expression in childhood B-precursor acute lymphocytic leukemia: A Pediatric Oncology Group study
9. Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia
10. A novel monoclonal antibody BI-3C5 recognises myeloblasts and non-B non-T lymphoblasts in acute leukaemias and CGL blast crises, and reacts with immature cells in normal bone marrow
11. QBEND/10, a new monoclonal antibody to endothelium: Assessment of its diagnostic utility in paraffin sections
12. The human progenitor cell antigen (CD34) is localized on endothelial cells, dermal dendritic cells, and perifollicular cells in formalin-fixed normal skin, and on proliferating endothelial cells and stromal spindle-shaped cells in Kaposi's sarcoma
13. Expression of the human hematopoietic progenitor cell antigen CD34 in vascular and spindle cell tumors
14. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia
15. Comparison of the reactivities of monoclonal antibodies QBEND10 (CD34) and BNH9 in vascular tumors
16. Expression of CD34 by solitary fibrous tumors of the pleura, mediastinum, and lung
17. CD-34 is expressed by a distinctive cell population in peripheral nerve, nerve sheath tumors, and related lesions
18. CD34 expression by gastrointestinal tract stromal tumors
19. Immunoreactivity for the human hematopoietic progenitor cell antigen (CD34) in lipomatous tumors
20. Spindle cell lipoma is strongly CD34 positive: An immunohistochemical study
21. CD34, and factor XIIIa in the differential diagnosis of dermatofibroma, and dermatofibrosarcoma protuberans
22. Expression of the human progenitor cell antigen CD34 (HPCA-1) distinguishes dermatofibrosarcoma protuberans from fibrous histiocytoma in formalin-fixed, paraffin-embedded tissue
23. Vimentin-negative epithelioid sarcoma: The value of an immunohistochemical panel that includes CD34
24. B72.3, and CD34 immunoreactivity in malignant epithelioid soft tissue tumors: Adjuncts in the recognition of endothelial neoplasms
25. Mammary myofibroblastoma with leiomyomatous differentiation
26. Myofibroblastoma of the breast with diverse differentiations
27. Anti-CD34 immunoperoxidase staining in paraffin sections of acute leukemia: Comparison with flow cytometric immunophenotyping
28. CD34: A review
29. Isolation and molecular characterization of the human CD34 gene
30. Molecular cloning of a cDNA encoding CD34, a sialomucin of human hematopoietic stem cells
31. Signaling and induction of enhanced cytoadhesiveness via the hematopoietic progenitor cell surface molecule CD34
32. The cytoplasmic domain of stem cell antigen CD34 is essential for cytoadhesion signaling but not sufficient for proliferation signaling
33. Two types of murine CD34 mRNA generated by alternative splicing
34. Differential sensitivity of CD34 epitopes to cleavage by Pasteurella haemolytica glycoprotease: Implications for purification of CD34-positive progenitor cells
35. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
36. Molecular basis for antibody cross-reactivity between the hepatitis C virus core protein and the host-derived GOR protein
37. Molecular basis for the binding promiscuity of an anti-p24 (HIV-1) monoclonal antibody
38. Crystallographic analysis of anti-p24 (HIV-1) monoclonal antibody cross-reactivity and polyspecificity
39. Molecular mimicry and autoimmune disease
40. Laser capture microdissection: Molecular analysis of tissue
41. Laser capture microdissection
42. Laser-capture microdissection: Opening the microscopic frontier to molecular analysis
43. Embryonic form of smooth muscle myosin heavy chain (SMemb/MHC-B) in gastrointestinal stromal tumor and interstitial cells of Cajal
44. Expression of c-kit (CD117) and Ki67 provides information about the possible cell of origin and clinical course of gastrointestinal stromal tumours
45. Interstitial cells of Cajal as precursors of gastrointestinal stromal tumors
46. CD34+ cells in human intestine are fibroblasts adjacent to, but distinct from, interstitial cells of Cajal
47. Activated protein kinase C directly phosphorylates the CD34 antigen on hematopoietic cells
48. Molecular mimicry: Frequency of reactivity of monoclonal antiviral antibodies with normal tissues
49. Immunocytochemical detection of MART-1 in fresh and paraffin-embedded malignant melanomas
50. Serological analysis of Melan-A (MART-1), a melanocyte-specific protein homogeneously expressed in human melanomas
51. Expression of melan-A (MART1) in benign melanocytic nevi and primary cutaneous malignant melanoma
52. Immunoreactivity for A103, an antibody to melan-A (Mart-1), in adrenocortical and other steroid tumors
53. The new melanoma markers: MART-1 and Melan-A (the NIH experience)
54. CD34 immunoexpression in stromal tumours of the gastrointestinal tract, and in mesenteric fibromatoses
55. Solitary fibrous tumor: Consistent CD34 immunoreactivity and occurrence in the orbit
56. Gastrointestinal stromal tumors: Value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas